TITLE

Tumour necrosis factor in the bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment

AUTHOR(S)
Murch, S H; MacDonald, T T; Wood, C B; Costeloe, K L
PUB. DATE
January 1992
SOURCE
Thorax;Jan1992, Vol. 47 Issue 1, p44
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66040276

 

Related Articles

  • Inflammatory mechanisms in neonatal chronic lung disease. Speer, C. P. // European Journal of Pediatrics. Supplement;1999, Vol. 158, pS18 

    Chronic lung disease (CLD) of preterm infants has a multifactorial aetiology. Oxygen toxicity, mechanical injury (barotrauma), volutrauma as well as prenatal and postnatal infections most likely contribute to pulmonary injury in the immature lung of preterm infants. There is sufficient evidence...

  • Inflammatory mechanisms in neonatal chronic lung disease. Speer, C. P. // European Journal of Pediatrics;1999, Vol. 158 Issue 13, pS18 

    Abstract Chronic lung disease (CLD) of preterm infants has a multifactorial aetiology. Oxygen toxicity, mechanical injury (barotrauma), volutrauma as well as prenatal and postnatal infections most likely contribute to pulmonary injury in the immature lung of preterm infants. There is sufficient...

  • Morbidity and survival in neonates ventilated for the respiratory distress syndrome. Greenough, Anne; Roberton, N.R.C. // British Medical Journal (Clinical Research Edition);2/23/1985, Vol. 290 Issue 6468, p597 

    Examines the morbidity associated with the respiratory distress syndrome. Rate of survival of infants with the syndrome; Number of mortality associated with respiratory distress syndrome; Treatment of respiratory distress syndrome.

  • Early inhaled nitric oxide in moderately hypoxemic preterm and term newborns with RDS: the RDS subgroup analysis of the Franco-Belgian iNO Randomized Trial. Truffert, P.; Llado-Paris, J.; Mercier, J.-C.; Dehan, M.; Bréart, G.; Bréart, G; Franco-Belgian iNO Study Group // European Journal of Pediatrics;2003, Vol. 162 Issue 9, p646 

    Investigates the effect of inhaled nitric oxide treatment in moderately hypoxemic newborns. Treatment of respiratory distress syndrome; Pulmonary vasodilation; Reduction of deterioration towards refractory hypoxemic respiratory failure in premature and near-term infants.

  • Lung Surfactant, Respiratory Failure, and Genes. Hallman, Mikko // New England Journal of Medicine;3/25/2004, Vol. 350 Issue 13, p1278 

    Offers a discussion on surfactant deficiency in infants who were dying of the respiratory distress syndrome, also known as hyaline membrane disease. Development of therapies including surfactant therapy; Decrease in mortality associated with the respiratory distress syndrome; Cases of the...

  • INCIDENCE AND RISK FACTORS IN CAUSING RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS WHOSE MOTHERS RECEIVED PROPHYLACTIC CORTICOSTEROIDS. Fraţilă-Băbeanu, Andreea; Iacob, Daniela // Jurnalul Pediatrului;jan-jun2015, Vol. 18 Issue 69/70, p29 

    Respiratory distress syndrome is one of the most common respiratory diseases in newborns, especially premature infants. The administration of antenatal steroids in women at risk of preterm birth is the most effective medication treatment. The goal of this therapy is to prevent respiratory...

  • The effect of early inhaled budesonide on pulmonary inflammation in infants with respiratory distress syndrome. Inwald, D. P.; Trivedi, K.; Murch, S. H.; Costeloe, K. // European Journal of Pediatrics;1999, Vol. 158 Issue 10, p815 

    Abstract The aim of this pilot study was to determine the effect of early inhaled budesonide on clinical and inflammatory parameters in preterm infants ventilated for respiratory distress syndrome. Conclusion Neither the inflammatory process associated with respiratory distress syndrome nor the...

  • Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. Fujii, A M; Patel, S M; Allen, R; Doros, G; Guo, C-Y; Testa, S // Journal of Perinatology;May2012, Vol. 32 Issue 5, p395 

    A correction to the article "Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome" in previous issue is presented.

  • Neurodevelopmental defects after steroid treatment of premature lung disease. Johnson, K. E. // Thorax;Jun2004, Vol. 59 Issue 6, p464 

    There has been much controversy in recent years regarding the early use of postnatal corticosteroids to treat preterm infants with respiratory distress syndrome (RDS). Short term respiratory benefits must be weighed against the potential for detrimental neurodevelopmental effects. This study...

  • Neonatologists are using much less dexamethasone. Shinwell, E. S.; Karplus, M.; Bader, D.; Dollberg, S.; Gur, I.; Weintraub, Z.; Arnon, S.; Gottfreid, E.; Zoritsky, A.; Mokhoul, I. R.; Reich, D.; Sirota, L.; Berger, I.; Kogan, A.; Yurman, S.; Goldberg, M.; Kohelet, D. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2003, Vol. 88 Issue 5, pF432 

    Two historical cohorts (1993-1994 and 2001) of preterm infants ventilated for respiratory distress syndrome were compared Dexamethasone administration fell from 22% to 6%. Chronic lung disease in survivors rose slightly from 13% to 17%, and mortality Fell from 21% to 15% (other causes). The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics